Review

POST-MASTECTOMY ADJUVANT RADIOTHERAPY: CONTRAVERSIAL INDICATIONS

• Maktav Dinçer

Surgical Highlights from the 40th San Antonio Breast Cancer Symposium: 5-9 December 2017, San Antonio, Texas

• Enver Özkurt

The Role of Primary Surgery in De Novo Metastatic Breast Carcinoma

• Berkay Demirors
• Berk Goktepe
• Hannah Medeck
• Serdar Ozbas
• Atilla Soran

Original Article

Adiponectin: A Predictor for Breast Cancer Survival?

• Hikmet Erhan Güven
• Lütfi Doğan
• Mehmet Ali Gülçelik
• Neşe Ersöz Gülçelik

The Clinical and Pathological Characteristics That Differentiate Cases With “Low Estrogen Receptor Expression” From Triple-Negative Breast Cancer

• Cem Karaali
• Mümin Emiroğlu
• Mustafa Değirmenci
• Murat Keser
• Semra Salimoğlu
• Canan Kelten Talu

A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma

• Nüvit Duraker
• Semih Hot
• Arzu Akan
• Pınar Özay Nayır

Survival Analysis of Triple Negative and Her2 Positive Breast Cancer Patients: Single Center Report

• Umut Varol
• Burcu Çakar
• İbrahim Yıldız
• Ceyda Tunakan Dalgıç
• Hatice Özışık
• Melih Özışık
• Burçak Karaca
• Bülent Karabulut
• Rüçhan Uslu

Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience

• Roshankumar Patil
• Prakash Pandit
• Vijay Palwe
• Shruti Kate
• Sucheta Gandhe
• Rahul Patil
• Yasam Venkata Ramesh
• Raj Nagarkar

Post-Traumatic Growth in the Early Survival Phase: From Turkish Breast Cancer Survivors’ Perspective

• Figen Şengün İnan
• Besti Üstün

Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer

• Fabiana Tonellotto
• Anke Bergmann
• Karen de Souza Abrahão
• Suzana Sales de Aguiar
• Marcelo Adeodato Bello
• Luiz Claudio Santos Thuler

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in cN0 Breast Cancer: Impact of HER2-Positive Status on Survival

• Juan Alors-Ruiz
• Salomé Sanz-Viedma
• Francisco Javier Fernández-Garcia
• Francisco Sendra-Portero

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine

• İzzet Doğan
• Nail Paksoy
• Naziye Ak
• Sezai Vatansever
• Pınar Saip
• Adnan Aydıner

Clinicopathological Characteristics, Treatment and Outcome of 123 Patients with Synchronous or Metachronous Bilateral Breast Cancer in a Swiss Institutional Retrospective Series

• Alexandre Huber
• Stéphanie J. Seidler
• Daniela E. Huber

Breast Cancer in Turkey; An Analysis of 20.000 Patients with Breast Cancer

• Vahit Özmen
• Tolga Özmen
• Volkan Doğru

Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes

• Çetin Ordu
• Kezban Nur Pilancı
• Gül Alço
• Filiz Elbüken
• Ülkühan İner Köksal
• Serkan İlgun
• Dauren Sarsenov
• Ayşe Esra Aydın
• Alper Öztürk
• Zeynep İyigün Erdoğan
• Filiz Ağaçayak
• Fatmagül Çubuk
• Coşkun Tecimer
• Yeşim Eralp
• Tomris Duymaz
• Fatma Aktepe
• Vahit Özmen

Favorable Long-Term Outcome in Male Breast Cancer

• Enver Özkurt
• Mustafa Tükenmez
• Ravza Yılmaz
• Neslihan Cabioğlu
• Mahmut Müslümanoğlu
• Ahmet Said Dinççağ
• Abdullah İğci
• Vahit Özmen

Impact of Detection Mode in a Large Cohort of Women Taking Part in a Breast Screening Program

• Marilina García
• Maximino Redondo
• Irene Zarcos
• Javier Louro
• Francisco Rivas-Ruiz
• Teresa Téllez
• Diego Pérez
• Francisco Medina Cano
• Kenza Machan
• Laia Domingo
• Maria del Mar Vernet
• Maria Padilla-Ruiz
• Xavier Castells
• Maria Sala

Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female Controls

• Joseph Liu
• Anupama Suresh
• Marilly Palettas
• Julie Stephens
• Akaansha Ganju
• Evan Morgan
• Mahmoud Kassem
• Yanjun Hou
• Anil Parwani
• Anne Noonan
• Raquel Reinbolt
• Jeffrey VanDeusen
• Sagar Sardesai
• Nicole Williams
• Mathew Cherian
• Gary Tozbikian
• Daniel G. Stover
• Maryam Lustberg
• Zaibo Li
• Bhuvaneswari Ramaswamy
• Robert Wesolowski

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience

• Yeşim Eralp
• Leyla Kılıç
• Gül Alço
• Gül Başaran
• Mutlu Doğan
• Dilek Dinçol
• Senem Demirci
• Fikri İçli
• Handan Onur
• Pınar Saip
• Ayfer Haydaroğlu

The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome

• Burcu Çakar
• Zeki Sürmeli
• Pınar Gürsoy Öner
• Elif Sıla Yelim
• Bülent Karabulut
• Ruchan Uslu

Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors

• Gül Kanyılmaz
• Berrin Benli Yavuz
• Meryem Aktan
• Mustafa Karaağaç
• Mehmet Uyar
• Sıddıka Fındık

Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer

• Ayşegül Sakin
• Mehmet Naci Aldemir

Effects of Primary Tumor Resection on Metastatic Breast Cancer Survival and the Predictive Power of Neutrophil: Lymphocyte Ratio on Prognosis

• Yaşar Çöpelci
• Umut Rıza Gündüz
• Bülent Dinç
• Nurhan Haluk Belen
• Şeyda Gündüz

Case Report

Long-term Survival after Lapatinib Rechallenge in Isolated Brain Metastasis of HER2-positive Breast Cancer

• Bülent Karagöz
• Alpaslan Özgün
• Levent Emirzeoğlu
• Tolga Tunçel
• Serkan Çelik
• Oğuz Bilgi
• Kemal Kara

Research Article

FACTORS THAT EFFECT OVERALL AND DISEASE FREE SURVIVAL IN BREAST CANCER PATIENTS

• Gül Dağlar
• Yunus Nadi Yüksek
• Uğur Gözalan
• Mutlu Doğanay
• Nuri Aydın Kama

Original Articles

FACTORS AFFECTING DISEASE FREE AND OVERALL SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPHY (LABC) (THE 10-YEAR RESULTS)

• Alper Öztürk
• Atilla Bozdoğan
• Derya Selamoğlu
• Mahmut Müslümanoğlu
• Abdullah İğci
• Vahit Özmen